Rossen RD - Search Results

1

Association of levels of circulating C1q binding macromolecules with induction chemotherapy response in head and neck cancer patients.

Schantz SP, Savage HE, Brown BW, Reuben JM, Hong WK, Rossen RD. Schantz SP, et al. Among authors: rossen rd. Cancer Res. 1988 Oct 15;48(20):5868-73. Cancer Res. 1988. PMID: 3262415

2

Immunologic determinants of head and neck cancer response to induction chemotherapy.

Schantz SP, Savage HE, Racz T, Liu FJ, Brown BW, Rossen RD, Hong WK. Schantz SP, et al. Among authors: rossen rd. J Clin Oncol. 1989 Jul;7(7):857-64. doi: 10.1200/JCO.1989.7.7.857. J Clin Oncol. 1989. PMID: 2472470

3

Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion.

Rossen RD, Michael LH, Hawkins HK, Youker K, Dreyer WJ, Baughn RE, Entman ML. Rossen RD, et al. Circ Res. 1994 Sep;75(3):546-55. doi: 10.1161/01.res.75.3.546. Circ Res. 1994. PMID: 8062428

4

Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo.

Rossen RD, Michael LH, Kagiyama A, Savage HE, Hanson G, Reisberg MA, Moake JN, Kim SH, Self D, Weakley S. Rossen RD, et al. Circ Res. 1988 Mar;62(3):572-84. doi: 10.1161/01.res.62.3.572. Circ Res. 1988. PMID: 3257722

5

Molecular basis of complement activation in ischemic myocardium: identification of specific molecules of mitochondrial origin that bind human C1q and fix complement.

Kagiyama A, Savage HE, Michael LH, Hanson G, Entman ML, Rossen RD. Kagiyama A, et al. Among authors: rossen rd. Circ Res. 1989 Mar;64(3):607-15. doi: 10.1161/01.res.64.3.607. Circ Res. 1989. PMID: 2783892

6

Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium.

Dreyer WJ, Smith CW, Michael LH, Rossen RD, Hughes BJ, Entman ML, Anderson DC. Dreyer WJ, et al. Among authors: rossen rd. Circ Res. 1989 Dec;65(6):1751-62. doi: 10.1161/01.res.65.6.1751. Circ Res. 1989. PMID: 2573438

7

Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.

Rossen RD, Crane MM, Morgan AC, Giannini EH, Giovanella BC, Stehlin JS, Twomey JJ, Hersh EM. Rossen RD, et al. Cancer Res. 1983 Jan;43(1):422-9. Cancer Res. 1983. PMID: 6600161

8

Association of circulating immune complexes with cytogenetic abnormalities but not with prognosis in acute nonlymphocytic leukemia.

Crane MM, Rossen RD, McCredie KB, Trujillo JM. Crane MM, et al. Among authors: rossen rd. Cancer Res. 1984 Jul;44(7):3125-31. Cancer Res. 1984. PMID: 6609770

9

Correlation of immune complexes in disseminated neuroblastoma with serum antibody to bovine serum albumin.

Beck DA, Rossen RD, Cangir A, DuBois DB. Beck DA, et al. Among authors: rossen rd. Cancer Res. 1983 Feb;43(2):879-85. Cancer Res. 1983. PMID: 6336661

10

The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.

Rossen RD, Reisberg MA, Hersh EM, Gutterman JU. Rossen RD, et al. J Natl Cancer Inst. 1977 May;58(5):1205-15. doi: 10.1093/jnci/58.5.1205. J Natl Cancer Inst. 1977. PMID: 323505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results